University of Bologna Clinical Trials
Sponsors / University of Bologna
ClinicalTrials.gov lists 122 trials for which University of Bologna is named as lead sponsor. Of these, 9 are recruiting, 2 are active without new recruitment, and 73 have completed. The registry records 4 terminated or withdrawn trials for University of Bologna. The most common reasons cited for termination include slow or insufficient recruitment, safety concerns. Planned participant enrollment across these trials sums to 203,216. Figures on this page are sourced from ClinicalTrials.gov and refreshed with each registry update.
122
Total Trials
9
Recruiting
2
Other Active
73
Completed
4
Terminated / Withdrawn
203,216
Total Enrollment
Termination reasons: Other50% · Recruitment25% · Safety25%
Recent Terminations
- Abdominal Infection"Insufficient rate of accrual due to the start of a concomitant similar study"
- Diffuse Large B-cell Lymphoma"The EC withdrawn the approval becuase of possible conflicts of interests between our Institute and Supporter (Celgene)"
- Peripheral T-cell Lymphoma"The EC withdrawn the approval becuase of possible conflicts of interests between our Institute and Supporter (Celgene)"
- Heart Transplantation"A cluster of adverse events in everolimus arm was noted."